CMS finalizes a rule to include list prices in TV drug ads, Medicare Advantage beneficiaries could save millions thanks to pending telehealth rules, and more news to know.
The value of OTCs to healthcare, the rise of specialty drug spending in Medicare Part D, CMS to test integrated care models for dual eligible beneficiaries, and more industry news to know.
The FDA grants final approval to the first generic naloxone nasal spray, Medicare and Social Security face uncertain financial futures, how Americans feel about ACA protections, and more industry news to know.
In recent months, generic effective rate (GER) clauses in pharmacy contracts have taken center stage. Here’s how they can affect your business.
The measles outbreak is still going strong, U.S. officials are awarding $350 million for research toward ending the opioid epidemic, patient influencers don’t trust pharma websites for health information, and more industry news from the past week.
Executives from the five largest PBMs appeared at a Senate Finance Committee hearing to discuss their roles in pharmaceutical supply chain.
PBMs say Big Pharma is responsible for high drug prices, Alexa has new HIPAA-compliant skills, D-SNP look-alike plans may soon be at risk, and more industry news from the past week.
The FDA wants to hear your experiences with CBD, the telemedicine market is on the rise, and more healthcare and pharmacy news to know this week.
Welcome to the first edition of Amplicare’s weekly news roundup. Each week, we’ll share five news stories to keep you up-to-date on what’s happening in the healthcare and pharmaceutical industries. Look for us every Friday afternoon.
Open Enrollment is upon us! The Amplicare team analyzed the data out there and identified key changes to help you help your patients this Open Enrollment.